Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Goetz · SciRah

Researcher profile · Semantic Scholar

M. Goetz

Share profile

M. Goetz — researcher profile on SciRah

h-index: 74
Works: 477
Citations: 26K

Most-cited papers

Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
W. Gradishar, M. Moran, J. Abraham, R. Aft +33 more
2022The Journal of the National Comprehensive Cancer Network797 citations
Semantic Scholar
Advances in systemic therapies for triple negative breast cancer
R. Leon-Ferre, M. Goetz
2023British medical journal497 citations Open access
Semantic Scholar
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
S. Johnston, M. Toi, J. O'Shaughnessy, P. Rastogi +20 more
2022The Lancet Oncology459 citations Open access
Semantic Scholar
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.
W. Gradishar, M. Moran, J. Abraham, V. Abramson +33 more
2023The Journal of the National Comprehensive Cancer Network420 citations Open access
Semantic Scholar
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
Rosie Bradley, J. Braybrooke, R. Gray, R. Hills +86 more
2022The Lancet Oncology210 citations Open access
Semantic Scholar
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
R. Leon-Ferre, S. Jonas, R. Salgado, S. Loi +29 more
2024Journal of the American Medical Association (JAMA)186 citations Open access
Semantic Scholar
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials
O. Pagani, B. Walley, G. Fleming, M. Colleoni +22 more
2022Journal of Clinical Oncology138 citations Open access
Semantic Scholar
Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010
Carolyn M. Larsen, Mariana Garcia Arango, Harika Dasari, M. A. Arciniegas Calle +9 more
2023JAMA Network Open83 citations Open access
Semantic Scholar
Breast Cancer, Version 3.2022
W. Gradishar, M. Moran, J. Abraham, R. Aft +33 more
202281 citations
Semantic Scholar
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
Nicola Cosgrove, D. Varešlija, S. Keelan, Ashuvinee Elangovan +15 more
2022Nature Communications80 citations Open access
Semantic Scholar
Implementation of Preemptive DNA Sequence-Based Pharmacogenomics Testing Across a Large Academic Medical Center: The Mayo-Baylor RIGHT 10K Study
Lie-Wei Wang, S. Scherer, S. Bielinski, D. Muzny +118 more
2022Genetics in Medicine65 citations Open access
Semantic Scholar
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer
Tufia C. Haddad, V. Suman, Antonino B. D’Assoro, Jodi M. Carter +19 more
2023JAMA Oncology61 citations Open access
Semantic Scholar
Cyclin-Dependent Kinase 4/6 Inhibitors for Treatment of Hormone Receptor–Positive, ERBB2-Negative Breast Cancer A Review
C. O'Sullivan, R. Clarke, M. Goetz, J. Robertson
2023JAMA Oncology60 citations
Semantic Scholar
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer
Jodi M. Carter, S. Chumsri, D. Hinerfeld, Yao-Hua Ma +22 more
2023Nature Communications45 citations Open access
Semantic Scholar
Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
Kevin J. Thompson, R. Leon-Ferre, J. Sinnwell, D. Zahrieh +16 more
2022NAR Cancer39 citations Open access
Semantic Scholar
Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG).
Marwan K. Tayeh, A. Gaedigk, M. Goetz, T. Klein +6 more
2022Genetics in Medicine37 citations Open access
Semantic Scholar
Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer
M. Goetz, E. Hamilton, M. Campone, S. Hurvitz +11 more
2023Clinical Cancer Research33 citations Open access
Semantic Scholar
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer
M. Polley, R. Leon-Ferre, S. Leung, A. Cheng +16 more
2021Breast Cancer Research and Treatment33 citations Open access
Semantic Scholar
The phase II MutHER study of neratinib alone and in combination with fulvestrant in HER2 mutated, non-amplified metastatic breast cancer.
Cynthia X. Ma, Jingqin R Luo, R. Freedman, T. Pluard +21 more
2022Clinical Cancer Research32 citations Open access
Semantic Scholar
Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer: Effects of Age and Tumor Ki67
J. Boughey, T. Hoskin, M. Goetz
2022Annals of Surgical Oncology29 citations Open access
Semantic Scholar
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).
E. Mayer, C. Fesl, D. Hlauschek, L. García-Estévez +29 more
2022Journal of Clinical Oncology28 citations Open access
Semantic Scholar
Clinical Behavior, Management, and Treatment Response of Estrogen Receptor Low (1–10%) Breast Cancer
Dan Moldoveanu, T. Hoskin, Courtney Day, Amy K. Schulze +2 more
2023Annals of Surgical Oncology25 citations
Semantic Scholar
Pharmacological targeting of androgen receptor elicits context-specific effects in estrogen receptor-positive breast cancer
Lixuan Wei, Huan-Yao Gao, Jia Yu, Huan Zhang +10 more
2022Cancer Research23 citations Open access
Semantic Scholar
Abstract GS1-05: Trial Assigning Individualized Options for Treatment (TAILORx): An Update Including 12-Year Event Rates
J. Sparano, R. Gray, D. Makower, K. Albain +12 more
2023Cancer Research20 citations
Semantic Scholar
Impact of BMI in Patients With Early Hormone Receptor–Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial
G. Pfeiler, D. Hlauschek, E. Mayer, C. Deutschmann +47 more
2023Journal of Clinical Oncology19 citations
Semantic Scholar
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H.pylori immunostimulatory bacterial transgene
Kimberly Viker, Michael B. Steele, I. Iankov, S. Concilio +9 more
2022Molecular Therapy: Methods & Clinical Development18 citations Open access
Semantic Scholar
Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2−, node-positive, high-risk early breast cancer
S. Paluch-Shimon, P. Neven, J. Huober, I. Çiçin +14 more
2023Therapeutic Advances in Medical Oncology17 citations Open access
Semantic Scholar
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer
Heba Alkhatib, Jason E. Conage-Pough, Sangita Roy Chowdhury, D. Shian +12 more
2024Molecular Cancer15 citations Open access
Semantic Scholar
Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer
Dan Moldoveanu, T. Hoskin, Courtney Day, Amy K. Schulze +2 more
2023Breast Cancer Research and Treatment15 citations Open access
Semantic Scholar
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer
K. Aspros, Jodi M. Carter, T. Hoskin, V. Suman +23 more
2022npj Breast Cancer15 citations Open access
Semantic Scholar
Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer
Ishwar N. Kohale, Jia Yu, Yong-Xian Zhuang, Xiaoya Fan +8 more
2022Cancers15 citations Open access
Semantic Scholar
Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer
Marshall D. Behrens, Robert J Stiles, Gennett M. Pike, Laura A. Sikkink +6 more
2022Molecular Therapy: Oncolytics14 citations Open access
Semantic Scholar
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study
G. Choong, Savannah S. Liddell, Roberto A. Leon Ferre, C. O'Sullivan +7 more
2022Breast Cancer Research and Treatment14 citations Open access
Semantic Scholar
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes
L. Lenz, C. Neff, C. Solimeno, Elizabeth S. Cogan +26 more
2023Breast Cancer Research and Treatment13 citations Open access
Semantic Scholar
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study
S. Tolaney, M. Beeram, J. Beck, A. Conlin +15 more
2022Frontiers in Oncology13 citations Open access
Semantic Scholar
Clinical Outcomes and Prognostic Factors In Triple-Negative Invasive Lobular Carcinoma of the Breast
U. Joshi, P. Budhathoki, S. Gaire, S. Yadav +14 more
2023Breast Cancer Research and Treatment10 citations Open access
Semantic Scholar
Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors
Xiao-Jia Tang, Kevin J. Thompson, K. Kalari, J. Sinnwell +11 more
2023Breast Cancer Research9 citations Open access
Semantic Scholar
Abstract OT2-11-06: SERENA-4: A Phase III comparison of AZD9833 (camizestrant) plus palbociclib, versus anastrozole plus palbociclib, for patients with ER-positive/HER2-negative advanced breast cancer who have not previously received systemic treatment for advanced disease
F. André, S. Im, P. Neven, R. Baird +11 more
2022Cancer Research8 citations
Semantic Scholar
Identification of a Notch transcriptomic signature for breast cancer
Eike-Benjamin Braune, Felix Geist, Xiao-Jia Tang, K. Kalari +12 more
2024Breast Cancer Research7 citations Open access
Semantic Scholar
A multiparameter molecular classifier to predict response to neoadjuvant lapatinib plus trastuzumab without chemotherapy in HER2+ breast cancer
J. Veeraraghavan, C. Gutierrez, C. de Angelis, R. Davis +23 more
2023Clinical Cancer Research7 citations Open access
Semantic Scholar
Abstract PD9-05: Stromal tumor-infiltrating lymphocytes identify early-stage triple-negative breast cancer patients with favorable outcomes at 10-year follow-up in the absence of systemic therapy: a pooled analysis of 1835 patients
R. Leon-Ferre, S. Jonas, R. Salgado, S. Loi +27 more
2023Cancer Research7 citations
Semantic Scholar
Abstract GS2-05: Randomized comparison of adjuvant aromatase inhibitor exemestane (E) plus ovarian function suppression (OFS) vs tamoxifen (T) plus OFS in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC): update of the combined TEXT and SOFT trials
M. Regan, B. Walley, G. Fleming, P. Francis +22 more
2022Cancer Research7 citations
Semantic Scholar
Lasofoxifene (LAS) plus abemaciclib (Abema) for treating ESR1-mutated ER+/HER2- metastatic breast cancer (mBC) after progression on prior therapies: ELAINE 2 study update.
S. Damodaran, H. Moore, I. Anderson, M. Cherian +4 more
2023Journal of Clinical Oncology6 citations Open access
Semantic Scholar
Disruption of estrogen receptor beta’s DNA binding domain impairs its tumor suppressive effects in triple negative breast cancer
K. Aspros, M. Emch, Xiyin Wang, M. Subramaniam +4 more
2023Frontiers in Medicine6 citations Open access
Semantic Scholar
Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer
G. Schwartz, P. Kaufman, K. Giridhar, J. Marotti +8 more
2023Clinical Cancer Research5 citations Open access
Semantic Scholar
Development and Validation of a Liquid Chromatography-Mass Spectrometry Assay for Quantification of Z- and E-Isomers of Endoxifen and its Metabolites in Plasma from Women with Estrogen Receptor Positive Breast Cancer
S. Buhrow, Emily J. Koubek, M. Goetz, M. Ames +1 more
2023Journal of chromatography. B, Analytical technologies in the biomedical and life sciences4 citations Open access
Semantic Scholar
A randomized phase 2 non-inferiority trial of (Z)-endoxifen and exemestane + goserelin as neoadjuvant treatment for premenopausal women with ER+/HER2- breast cancer (EVANGELINE).
M. Goetz, V. Suman, L. Mina, Pooja P. Advani +3 more
2023Journal of Clinical Oncology3 citations
Semantic Scholar
Abstract P4-07-56: Mayo Clinic Enterprise patterns of growth-factor utilization for sacituzumab govitecan (SG)-induced neutropenia among patients with metastatic triple negative breast cancer
Kaylee Clark, Jamie L. Carroll, A. Moreno-Aspitia, Brenda J. Ernst +8 more
2023Cancer Research3 citations
Semantic Scholar
PDJ amplicon in triple negative breast cancer
A. Roesler, S. Malasi, Lori K. Koslosky, Peter Hartmayer +10 more
2023Scientific Reports3 citations Open access
Semantic Scholar
Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen Metabolism
Emily J. Koubek, S. Buhrow, Stephanie L. Safgren, L. Jia +3 more
2022Drug Metabolism And Disposition3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Boughey×14
Invite
J. Boughey — researcher profile on SciRah
R. Leon-Ferre×12
Invite
R. Leon-Ferre — researcher profile on SciRah
Jodi M. Carter×11
Invite
Jodi M. Carter — researcher profile on SciRah
K. Kalari×8
Invite
K. Kalari — researcher profile on SciRah

×7

Invite

H. Burstein — researcher profile on SciRah

Invite

F. Couch — researcher profile on SciRah

Tufia C. Haddad×6

Invite

Tufia C. Haddad — researcher profile on SciRah

Invite

V. Suman — researcher profile on SciRah

Invite

J. Ingle — researcher profile on SciRah

Lie-Wei Wang×6

Invite

Lie-Wei Wang — researcher profile on SciRah

Invite

K. Giridhar — researcher profile on SciRah

Invite

J. Sinnwell — researcher profile on SciRah